skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Tetrahydrocannabinol vs. Prochlorperazine: the effects of two antiemetics on patients undergoing radiotherapy

Journal Article · · Radiology; (United States)

The authors tested the effectiveness of orally administred delta-9-tetrahydrocannabinol (THC) as compared to prochlorperazine for the alleviation of symptoms, such as vomiting and nausea, experienced by patients receiving radiotherapy. The test subjects rated the severity of their illness, as well as the extent of their subsequent moods, their level of concentration, their amount of physical activity, and their desire for social interaction. They chose the drug they preferred and recorded its side effects. The use of THC was slightly more beneficial than the use of prochlorperazine.

Research Organization:
Univ. of California, Los Angeles
OSTI ID:
5020771
Journal Information:
Radiology; (United States), Vol. 150:2
Country of Publication:
United States
Language:
English

Similar Records

Prevention of acute radiation-induced proctosigmoiditis by balsalazide: A randomized, double-blind, placebo controlled trial in prostate cancer patients
Journal Article · Thu Dec 01 00:00:00 EST 2005 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:5020771

TRAIL OF A NEW ANTIEMETIC AGENT, TIGAN IN RADIATION SICKNESS
Journal Article · Thu Jun 01 00:00:00 EDT 1961 · Journal de Medecine de Bordeaux et du Sud-Ouest (France) Superseded by Bordeaux Med. · OSTI ID:5020771

Ondansetron. Therapeutic use as an antiemetic
Journal Article · Mon Apr 01 00:00:00 EST 1991 · JDBP (Journal of Developmental and Behavioral Pediatrics) (Baltimore); (United States) · OSTI ID:5020771